Lexaria Short Long Term Debt Total from 2010 to 2025

LEXX Stock  USD 1.47  0.08  5.16%   
Lexaria Bioscience Short and Long Term Debt Total yearly trend continues to be fairly stable with very little volatility. Short and Long Term Debt Total will likely drop to about 117.4 K in 2025. During the period from 2010 to 2025, Lexaria Bioscience Short and Long Term Debt Total regression line of annual values had r-squared of  0.43 and arithmetic mean of  397,223. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2006-11-30
Previous Quarter
137.4 K
Current Value
130.7 K
Quarterly Volatility
600.1 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lexaria Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexaria Bioscience's main balance sheet or income statement drivers, such as Depreciation And Amortization of 129 K, Interest Expense of 107.8 K or Other Operating Expenses of 7.5 M, as well as many indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0 or PTB Ratio of 57.61. Lexaria financial statements analysis is a perfect complement when working with Lexaria Bioscience Valuation or Volatility modules.
  
Check out the analysis of Lexaria Bioscience Correlation against competitors.

Latest Lexaria Bioscience's Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Lexaria Bioscience Corp over the last few years. It is Lexaria Bioscience's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexaria Bioscience's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Lexaria Short Long Term Debt Total Regression Statistics

Arithmetic Mean397,223
Geometric Mean166,793
Coefficient Of Variation158.45
Mean Deviation464,347
Median156,101
Standard Deviation629,391
Sample Variance396.1B
Range1.9M
R-Value(0.66)
Mean Square Error241.9B
R-Squared0.43
Significance0.01
Slope(86,700)
Total Sum of Squares5.9T

Lexaria Short Long Term Debt Total History

2025117.4 K
2024123.6 K
2023137.4 K
2022164 K
202150 K
202097.3 K

About Lexaria Bioscience Financial Statements

Lexaria Bioscience investors use historical fundamental indicators, such as Lexaria Bioscience's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Lexaria Bioscience. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total123.6 K117.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Lexaria Stock Analysis

When running Lexaria Bioscience's price analysis, check to measure Lexaria Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexaria Bioscience is operating at the current time. Most of Lexaria Bioscience's value examination focuses on studying past and present price action to predict the probability of Lexaria Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lexaria Bioscience's price. Additionally, you may evaluate how the addition of Lexaria Bioscience to your portfolios can decrease your overall portfolio volatility.